Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehydroepiandrosterone sulphate (DHEAS)

Immunology

Volumn 90, Issue 3, 1997, Pages 344-349

  Araghi Niknam, M ^a   Liang, B ^a   Zhang, Z ^a   Ardestani, S K ^a   Watson, R R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6; PRASTERONE SULFATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LEUKEMIA; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROVIRUS INFECTION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031046472     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1997.00344.x     Document Type: Article

References (41)

1. SCHWARTZ A.G., FAIRMAN K.K. & PASHKO L.L. (1990) The biological significance of DHEA. In: The Biological Role of Dehydroepiandrosterone. (eds M. Kalimi & W. Regelson), p. 7. Walter De Gruyter, New York.
2. ORENTREICH N., BRIND J.L., RIZER R.L. et al. (1984) Aging changes and sex differences in serum Dehydroepiandrosterone sulfate concentration throughout adulthood. J Clin Endocrinol 57, 624.
3. MIGEON C.J., KELLER A.R. & LAWRENCE B. (1957) DHEA and androsterone levels in human plasma. Effects of age and sex; day-to-day and diurnal variations. J Clin Endocrinol Metab 17, 1051.
4. JACOBSON M.A., FUSARO R.E., GALMARINI M. et al. (1991) Decreased serum DHEA is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 164, 864.
5. RUDMAN D., SHELTY R.R. & MATTSON D.E. (1990) Plasma DHEA-S in nursing home men. J Amer Geriat Soc 38, 421.
6. GORDON G.B., HELZLOSOUER K.J., ALBERG A.J. et al. (1993) Serum levels of DHEA and DHEAS and risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prevention 2, 33.
7. YANG J.Y., SCHWARTZ A. & HENDERSON E.E. (1994) Inhibition of 3′Azido-3′ deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Biochem Biophys Res Commun 201, 1424.
8. MUDLER J.W., FRISSEN P.H., KRIJENEN P. et al. (1992) E Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic HIV-infected men. J Infect Dis 165, 413.
9. DAYNES R.A., ARANEO A.B., ERSHLER W.B. et al. (1993) Altered regulation of 1L-6 production with normal aging. Possible linkage to the age-associated decline in DHEA and its sulfated derivatives. J Immunol 150, 5219.
10. VLACH J. & PITHA M. (1992) Activation of human immunodeficiency virus type 1 provirus in T-cell and macrophages is associated with induction of inducer-specific NF-Kβ binding proteins. Virology 187, 63.
11. SCHRECK R., RIEBER O. & BAUERLE P.A. (1991) Intermediates as apparently widely used messenger in the activation of the NF-Kβ transcription factor and HIV-1. Embo J 10, 2247.
12. URSINI M.V., LETTIERI T., BRADDOCK M. & MARTINI G. (1993) Enhanced activity of human G6PD promoter transfected in Helacell producing high levels of HIV-1 TAT. Virology 196, 338.
13. CHREISTIFF N., GHARAKHANIAN S., THOBIE N. et al. (1992) Evidence for changes in adrenal and testicular steroids during HIV infection. J AIDS 5, 841.
14. POLI G. & FAUCI, A.S. (1995) Role of cytokine in the pathogenesis of human immunodeficiency virus infection. In: Human Cytokine: Their Role in Disease and Therapy. (eds B.B. Aggrawal & R.K. Puri) pp. 421 50. Blackwell Science, Oxford.
15. WANG Y., ARDESTANI S.K., LIANG B., BECKHAM C. & WATSON R.R. (1994) Anti-interleukin-4 monoclonal antibody and IFN-γ administration retards development of immune dysfunction and cytokine dysregulation during murine AIDS. Immunology 83, 384.
16. WANG Y., HUANG D.S., GIGGER PT. & WATSON R.R. (1993) The kinetics of imbalanced cytokine production by T cells and macrophage during the murine AIDS. Adv Biosci 86, 335.
17. + subset regulation in vivo infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 148, 182.
18. YUNG Y.J., SCHWARTZ A. & HEDERSON E.E. (1993) Inhibition of HIV-1 latency reactivation by DHEA and analog of DHEA. AIDS Res Human Retrovir 9, 747.
19. WATSON R.R. (1989) Mini review of murine models for acquired immune deficiency syndrome. Life Sci 44, 111.
20. WANG Y., HUNG D.S., GIGER P.T. & WATSON R.R. (1994) Influence of chronic dietary ethanol on cytokine production by murine splenocytes and lymphocyte. Alcohol Clin Exp Res 18, 64.
21. OTT L. (1988) A nonparametric alternative: the kruskal- Wallace test. In: An Introduction to Statistical Methods and Data Analysis, (ed L. Ott), edn 3, p. 422. PWS-Kent Publishers, Boston, MA.
22. DUNCAN D.B. (1955) Multiple range and multi F-test. Biometrics 11, 1.
23. BOUE F., WALLON C., GOUJARD C. et al. (1992) HIV induced IL-6 production by human B lymphocytes: Role of IL-4. J Immunol 148, 3761.
24. MARKINNODAN T. & MARGUERITE M.B.K. (1980) Age influence on the immune system. Adv Immunol 29, 287.
25. DAYNES R.A., DONALD J., ARANEO D. & ARANEO B.A. (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T cells. Europ J Immunol 20, 793.
26. H2 switch is a critical step in the etiology of HIV infection, Immunol Today 14, 107.
27. SHER A., GAZZINELLI R.T., OSWALD I.P. et al. (1992) Role of T-cell derived cytokines in the down regulation of immune responses in parasitic and retroviral infection. Immunol Rev 127, 183.
28. WATSON R.R., WANG J.Y., DEHGHANPISHEH K. et al. (1995) T cell receptor Vβ complementarity determining region 1 peptides administration moderates immune dysregulation induced by murine retrovirus infection. J Immunol 155, 2282.
29. KANAGAWA O., VAUPEL B.A., GAYAMA S. et al. (1993) Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 262, 240.
30. THOMAN M.L. & WEIGLE W.O. (1989) The cellular and subcellular basis of immunosecescence. Adv Immunol 46, 221.
31. ARANEO B.A., DOWELL T., DIEGLE M. & DAYNES R.A. (1991) DHEA exerts a depressive influence on the production of IL-4, IL-5, IFN-β, but not the IL-2 by activated murine T cell. Blood 79, 689.
32. WEINDRUCH R.. MCFEEETERS G. & WALFORD R.L. (1984) Food intake reduction and immunologic alteration in mice fed DHEA. Exp Gerontol 19, 297.
33. WATSON R.R. (1995) Prevention of immune dysfunction by dehydroepiandrosterone in aging, chronic AIDS and leukemia patients. Exp Opin Invest Drugs 4, 147.
34. HIRANO T. & KISHIMOTO T. (1991) IL-6. In: Peptide Growth Factors and their Receptors. (eds M. B. Sporn & A. B. Roberts), Handbook of Experimental Pharmacology, vol. 95, part 1. Springer-Verlag, Berlin.
35. MOSIER D.E. (1985) Animal model for retrovirus induced immunodeficiency disease. Immunol Invest 15, 233.
36. DAYNES R.A. & ARANEO B.A. (1992) Programming of lymphocyte responses to activation: extrinsic factors, provided microenviornmentally, confer flexibility and compartmentalization to T cell function. Chem Immun 54, 1.
37. MULDER J.W., FRISSEN J., KRIJNEN P. et al. (1992) Dehydroepiandrosterone as a predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165, 413.
38. RETTI J.E. & HOFFBRAND A.V. (1994) IL-4 inhibits proliferation and spontaneous cytokine release by CLL cells. Leukemia Res 18, 55.
39. CLERICI M., HAKIM F.T., VENZON D.J. et al. (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91, 759.
40. ARANEO B.A., WOODS M.L. & DAYNES R.A. (1993) Reversal of the immunosenescent phenotype by DHEA treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 167, 834.
41. SUZUKI T., SUZUKI N., DAYNES R.A. et al. (1991). Dehydroepiandrosterone enhances IL-2 production cytotoxic effector function of human T cell. Clin Immunol Immunopathol 61, 202.